)
Toleranzia (TOL) investor relations material
Toleranzia Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Operating loss widened to SEK -2,835 thousand for Q2 and SEK -6,128 thousand for H1 2025, reflecting increased R&D and merger-related costs.
Extraordinary General Meeting approved merger with Flerie AB; delisting from Nasdaq First North Growth Market expected August 18, 2025.
SEK 20 million credit facility secured from Flerie AB to support clinical trial preparations and ongoing operations.
Focus remains on advancing TOL2 for myasthenia gravis and TOL3 for ANCA vasculitis, with clinical trial preparations ongoing.
Financial highlights
Q2 operating loss: SEK -2,835 thousand (vs. -1,788 thousand Q2 2024); H1 operating loss: SEK -6,128 thousand (vs. -3,429 thousand H1 2024).
Cash flow from operating activities: SEK -3,978 thousand in Q2 (vs. -40 thousand Q2 2024); SEK -7,168 thousand in H1 (vs. -3,699 thousand H1 2024).
Investments in intangible assets: SEK 4,073 thousand in Q2 (vs. 7,414 thousand Q2 2024); SEK 9,244 thousand in H1 (vs. 12,101 thousand H1 2024).
Cash and bank balances at June 30: SEK 2,366 thousand (vs. 2,293 thousand June 2024).
Earnings per share: SEK -0.01 for Q2 (vs. 0.01 Q2 2024); SEK -0.02 for H1 (vs. 0.01 H1 2024).
Outlook and guidance
Clinical trial for TOL2 will not commence without full financing; additional capital injections required.
Upon merger completion, operations will continue under Flerie AB, with Toleranzia's pipeline expected to benefit from broader ownership and resources.
- Toleranzia submitted its TOL2 trial application and secured major warrant funding commitments.TOL
Q3 202413 Jun 2025 - Operating losses narrowed as TOL2 nears clinical trials and financing options strengthen.TOL
Q2 202413 Jun 2025 - Q1 2025 saw Toleranzia advance TOL2 and pursue a merger amid urgent funding needs.TOL
Q1 20256 Jun 2025 - TOL2 clinical trial approved, SEK 37M raised, and full-year loss at KSEK -10,248.TOL
Q4 20245 Jun 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)